. . . . . . . . . "for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms and as an adjunctive in systemic sulfonamide therapy of trachoma escherichia coli staphylococcus aureus streptococcus pneumoniae streptococcus viridans group haemophilus influenzae klebsiella species and enterobacter species topically applied sulfonamides do not provide adequate coverage against neisseria species serratia marcescens and pseudomonas aeruginosa a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "edWC4mZmMHaT0m1YNws72+NizBxzIjkN2obj/g4LAi8hQFRjb5BFHxIQRgV+1PV44tNa9t709cB9CRAV8f3V7MfSlhcNzGj5TZ2Xl1oyc1M7ADnEHPWxodcCNzVz3FCj1+gQN8Rx9wk1go2sEfDGOjoKf8wbDiTvbzHbA2ZzTBw=" . . "2021-06-12T15:48:09.177+02:00"^^ . . . . .